Literature DB >> 29788348

Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Rosalind J Carter1, Reynold G B Senesi2, Peter Dawson3, Ibrahim Gassama2, S A S Kargbo4, Carey R Petrie3, Mohamed Hashim Rogers2, Mohamed Samai2, Elizabeth T Luman1.   

Abstract

Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29788348      PMCID： PMC5961184          DOI： 10.1093/infdis/jiy094

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  12 in total

1.  Sample size slippages in randomised trials: exclusions and the lost and wayward.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

2.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Authors:  F T Cutts; S M A Zaman; G Enwere; S Jaffar; O S Levine; J B Okoko; C Oluwalana; A Vaughan; S K Obaro; A Leach; K P McAdam; E Biney; M Saaka; U Onwuchekwa; F Yallop; N F Pierce; B M Greenwood; R A Adegbola
Journal:  Lancet       Date:  2005 Mar 26-Apr 1       Impact factor: 79.321

3.  Recruitment and retention of women for clinical leiomyoma trials.

Authors:  Desireé McCarthy-Keith; Sahadat Nurudeen; Alicia Armstrong; Eric Levens; Lynnette K Nieman
Journal:  Contemp Clin Trials       Date:  2009-09-27       Impact factor: 2.226

4.  Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.

Authors:  Stephen B Kennedy; James D Neaton; H Clifford Lane; Mark W S Kieh; Moses B F Massaquoi; Nancy A Touchette; Martha C Nason; Dean A Follmann; Fatorma K Boley; Melvin P Johnson; Gregg Larson; Francis N Kateh; Tolbert G Nyenswah
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

5.  Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.

Authors:  Stephen B Kennedy; Fatorma Bolay; Mark Kieh; Greg Grandits; Moses Badio; Ripley Ballou; Risa Eckes; Mark Feinberg; Dean Follmann; Birgit Grund; Swati Gupta; Lisa Hensley; Elizabeth Higgs; Krisztina Janosko; Melvin Johnson; Francis Kateh; James Logue; Jonathan Marchand; Thomas Monath; Martha Nason; Tolbert Nyenswah; François Roman; Eric Stavale; Julian Wolfson; James D Neaton; H Clifford Lane
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

6.  Implementing an Ebola Vaccine Study - Sierra Leone.

Authors:  Marc-Alain Widdowson; Stephanie J Schrag; Rosalind J Carter; Wendy Carr; Jennifer Legardy-Williams; Laura Gibson; Durodami R Lisk; Mohamed I Jalloh; Donald A Bash-Taqi; Samuel A Sheku Kargbo; Ayesha Idriss; Gibrilla F Deen; James B W Russell; Wendi McDonald; Alison P Albert; Michelle Basket; Amy Callis; Victoria M Carter; Kelli R Clifton Ogunsanya; Julianne Gee; Robert Pinner; Barbara E Mahon; Susan T Goldstein; Jane F Seward; Mohamed Samai; Anne Schuchat
Journal:  MMWR Suppl       Date:  2016-07-08

Review 7.  Systematic review identifies number of strategies important for retaining study participants.

Authors:  Karen A Robinson; Cheryl R Dennison; Dawn M Wayman; Peter J Pronovost; Dale M Needham
Journal:  J Clin Epidemiol       Date:  2007-05-10       Impact factor: 6.437

8.  Lessons in participant retention in the course of a randomized controlled clinical trial.

Authors:  Olubukola T Idoko; Olumuyiwa A Owolabi; Aderonke A Odutola; Olatunde Ogundare; Archibald Worwui; Yauba Saidu; Alison Smith-Sanneh; Abdoulie Tunkara; Gibbi Sey; Assan Sanyang; Philip Mendy; Martin O C Ota
Journal:  BMC Res Notes       Date:  2014-10-09

9.  Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency.

Authors:  Gregg S Larson; Beth R Baseler; Marie L Hoover; Jerome F Pierson; Jemee K Tegli; Melvin P Johnson; Mark W S Kieh; Laura A McNay; Wissedi Sio Njoh
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

10.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors:  Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal:  Lancet       Date:  2016-12-23       Impact factor: 79.321
View more
  4 in total

1.  Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Authors:  Augustin E Fombah; Susan T Goldstein; Olamide D Jarrett; Mohamed I Jalloh; Jill El-Khorazaty; Durodami Radcliffe Lisk; Jennifer Legardy-Williams; Dudley A Pratt; Peter M George; James B W Russell; Stephanie J Schrag; Peter Dawson; Gibrilla F Deen; Wendy Carr; Robert Lindblad; Faustine James; Mohamed M Bah; John F Yillia; Jibao D Sandy; Patrick E Turay; Muhammad-Abbas Conteh; Laurence Slutsker; Barbara E Mahon; Mohamed Samai; Jane F Seward
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

2.  Conducting clinical research in a resource-constrained setting: lessons from a longitudinal cohort study in The Gambia.

Authors:  Abdulazeez Imam; Oghenebrume Wariri; Tida Dibbasey; Abdoulie Camara; Anthony Mendy; Assan N Sanyang; Masaneh Ceesay; Samba Jallow; Abdoulie E Jallow; Kaddijatou Bah; Njilan Johnson; Ebrima Trawally; Dawda Sowe; Alansana Darboe; Beate Kampmann; Olubukola T Idoko
Journal:  BMJ Glob Health       Date:  2021-08

3.  Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.

Authors:  Rachel Colin-Jones; Mila Shakya; Merryn Voysey; Katherine Theiss-Nyland; Nicola Smith; Dikshya Pant; Xinxue Liu; Susan Tonks; Olga Mazur; Yama G Farooq; Sarah Kelly; Anup Adhikari; Sabina Dongol; Abhilasha Karkey; Shrijana Shrestha; Buddha Basnyat; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

4.  Pediatric Participant Retention Rates in a Longitudinal Malaria Immunology Study.

Authors:  Anushay Mistry; Boaz Odwar; Fredrick Olewe; Jonathan Kurtis; Ann M Moormann; John Michael Ong'echa
Journal:  Am J Trop Med Hyg       Date:  2022-04-18       Impact factor: 3.707
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.